Mohammed Haider

Dr. Mohammed Haider

Kuwait University, Kuwait City, Al ‘Āşimah, Kuwait
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2017 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ADAlison M. Day
Alison M. Day
DSDeborah A. Smith
Deborah A. Smith
MIMélanie A. C. Ikeh
Mélanie A. C. Ikeh
MHMohammed Haider
Mohammed Haider
CHCarmen M. Herrero-De-Dios
Carmen M. Herrero-De-Dios
Janet QuinnJanet Quinn
Janet Quinn
The Ypd1 phosphorelay protein is a central constituent of fungal two-component signal transduction pathways. Inhibition of Ypd1 in Saccharomyces cerevisiae and Cryptococcus neoformans is lethal due to the sustained activation of the ‘p38-related’ Hog1 stress-activated protein kinase (SAPK). As two-component signalling proteins are not found in animals, Ypd1 is considered to be a prime antifungal target. However, a major fungal pathogen of humans, Candida albicans, can survive the concomitant sustained activation of Hog1 that occurs in cells lacking YPD1. Here we show that the sustained activation of Hog1 upon Ypd1 loss is mediated through the Ssk1 response regulator. Moreover, we present evidence that C. albicans survives SAPK activation in the short-term, following Ypd1 loss, by triggering the induction of protein tyrosine phosphatase-encoding genes which prevent the accumulation of lethal levels of phosphorylated Hog1. In addition, our studies reveal an unpredicted, reversible, mechanism that acts to substantially reduce the levels of phosphorylated Hog1 in ypd1Δ cells following long-term sustained SAPK activation. Indeed, over time, ypd1Δ cells become phenotypically indistinguishable from wild-type cells. Importantly, we also find that drug-induced down-regulation of YPD1 expression actually enhances the virulence of C. albicans in two distinct animal infection models. Investigating the underlying causes of this increased virulence, revealed that drug-mediated repression of YPD1 expression promotes hyphal growth both within murine kidneys, and following phagocytosis, thus increasing the efficacy by which C. albicans kills macrophages. Taken together, these findings challenge the targeting of Ypd1 proteins as a general antifungal strategy and reveal novel cellular adaptation mechanisms to sustained SAPK activation. As fungi-attributed human deaths are increasing, there is an urgent need to develop new antifungal treatments. Two-component related proteins, such as the Ypd1 phosphorelay protein, have been heralded as antifungal targets as they are not found in humans and because inactivation of YPD1 in several different fungi causes sustained SAPK activation and cell death. However, we have discovered that inactivation of YPD1 in the major human pathogen, Candida albicans, actually enhances virulence. Furthermore, we reveal that this fungus adapts to the sustained activation of the Hog1 SAPK triggered by Ypd1 loss by mounting distinct mechanisms that actively reduce the level of phosphorylated Hog1. These findings question the validity of Ypd1 proteins as broad-spectrum antifungal targets and provide insights into the cellular adaptation to sustained SAPK activation.

15 April 2014 in Journal of Virology
Verified
Journal Article
Open access
PDF file
KRKathryn H. Richards
Kathryn H. Richards
RDRosella Doble
Rosella Doble
CWChristopher W. Wasson
Christopher W. Wasson
MHMohammed Haider
Mohammed Haider
Eric BlairEric Blair
Eric Blair
Andrew MacdonaldAndrew Macdonald
Andrew Macdonald
Human papillomavirus (HPV) can successfully evade the host immune response to establish a persistent infection. We show here that expression of the E7 oncoprotein in primary human keratinocytes results in increased production of interleukin-18 (IL-18) binding protein (IL-18BP). This anti-inflammatory cytokine binding protein is a natural antagonist of IL-18 and is necessary for skin homeostasis. We map increased IL-18BP production to the CR3 region of E7 and demonstrate that this ability is shared among E7 proteins from different HPV types. Furthermore, mutagenesis shows that increased IL-18BP production is mediated by a gamma-activated sequence (GAS) in the IL-18BP promoter. Importantly, the increased IL-18BP levels seen in E7-expressing keratinocytes are capable of diminishing IL-18-mediated CD4 lymphocyte activation. This study provides the first evidence for a virus protein that targets IL-18BP and further validates E7 as a key component of the HPV immune evasion armor. IMPORTANCE Infection with human papillomavirus is a leading cause of morbidity and mortality worldwide. This study demonstrates that the E7 protein increases production of the anti-inflammatory IL-18BP, a major regulator of epithelial homeostasis. A number of E7 proteins can increase IL-18BP production, and a region within the CR3 of E7 is necessary for mediating the increase. A consequence of increased IL-18BP production is a reduction in CD4-positive lymphocyte activation in response to IL-18 costimulation. These findings may shed light on the immune evasion abilities of HPV.

8 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMohammed Haider
Mohammed Haider
IDIvy M. Dambuza
Ivy M. Dambuza
PAPatawee Asamaphan
Patawee Asamaphan
MSMark Stappers
Mark Stappers
DRDelyth Reid
Delyth Reid
LELars P. Erwig
Lars P. Erwig
Phagocytosis is a receptor-mediated process critical to innate immune clearance of pathogens. It proceeds in a regulated sequence of stages: (a) migration of phagocytes towards pathogens, (b) recognition of PAMPs and binding through PRRs, (c) engulfment and internalisation into phagosomes, (d) phagosome maturation, and (e) killing of pathogen or host cells. However, little is known about the role that individual receptors play in these discrete stages in the recognition of fungal cells. In a previous study, we found that dectin-2 deficiency impacted some but not all stages of macrophage-mediated phagocytosis of Candida glabrata. Because the C-type lectin receptor dectin-2 critically requires coupling to the FcRγ chain for signalling, we hypothesised that this coupling may be important for regulating phagocytosis of fungal cargo. We therefore examined how deficiency in FcRγ itself or two receptors to which it couples (dectin-2 and mincle) impacts phagocytosis of six fungal organisms representing three different fungal taxa. Our data show that deficiency in these proteins impairs murine bone marrow-derived macrophage migration, engulfment, and phagosome maturation, but not macrophage survival. Therefore, FcRγ engagement with selective C-type lectin receptors (CLRs) critically affects the spatio-temporal dynamics of fungal phagocytosis.

28 August 2022 in Cells
Verified
Journal Article
Open access
PDF file
MHMohammed Haider
Mohammed Haider
ZAZahraa Albaqsumi
Zahraa Albaqsumi
FAFahd Al-Mulla
Fahd Al-Mulla
Rasheed AhmadRasheed Ahmad
Rasheed Ahmad
FAFatema Al-Rashed
Fatema Al-Rashed
The C-type lectin receptors (CLRs) Dectin-1 and Dectin-2 are involved in several innate immune responses and are expressed mainly in dendritic cells, monocytes, and macrophages. Dectin-1 activation exacerbates obesity, inflammation, and insulin resistance/type 2 diabetes (T2D). However, the role of Dectin-2 is not clear in T2D. This study aims to evaluate the expression and function of Dectin-2 in peripheral blood mononuclear cells (PBMCs) isolated from diabetic patients and non-diabetic controls. Flow-cytometry and qRT-PCR were performed to evaluate the expression of Dectin-2 in different leukocyte subpopulations isolated from T2D patients (n = 10) and matched non-diabetic controls (n = 11). The functional activity of Dectin-2 was identified in PBMCs. CRP, IL-1β, and TNF-α concentrations were determined by ELISA. siRNA transfection and Western blotting were performed to assess p-Syk and p-NF-kB expression. siRNA transfection was performed to knock down the gene of interest. Our results show that Dectin-2 expression was the highest in monocytes compared with other leukocyte subpopulations. The expression of Dectin-2 was significantly increased in the monocytes of T2D patients compared with non-diabetic controls. Dectin-2 expression positively correlated with markers of glucose homeostasis, including HOMA-IR and HbA1c. The expression of inflammatory markers was elevated in the PBMCs of T2D patients. Interestingly, SOCS3, a negative regulator of inflammation, was expressed significantly lowlier in the PBMCs of T2D patients. Moreover, SOCS3 expression was negatively correlated with Dectin-2 expression level. The further analysis of inflammatory signaling pathways showed a persistent activation of the Dectin-2-Syk-NFkB pathway that was instigated by the diminished expression of SOCS3. Dectin-2 activation failed to induce SOCS3 expression and suppress subsequent inflammatory responses in the PBMCs of diabetic patients. siRNA-mediated knockdown of SOCS3 in PBMCs displayed a similar inflammatory phenotype to diabetic PBMCs when exposed to Dectin-2 ligands. Altogether, our findings suggest that elevated Dectin-2 and its relationship with SOCS3 could be involved in the abnormal immune response observed in T2D patients.

29 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MHMohammed Haider
Mohammed Haider
FAFatema Al-Rashed
Fatema Al-Rashed
ZAZahraa Albaqsumi
Zahraa Albaqsumi
KAKHALED A A A ALOBAID
KHALED A A A ALOBAID
RARawan Alqabandi
Rawan Alqabandi
Rasheed AhmadRasheed Ahmad
Rasheed Ahmad
Atherosclerosis is a chronic degenerative disorder characterized by lipid-dense plaques and low-grade inflammation affecting arterial walls. Foamy macrophages are important in the formation of atherosclerotic plaques and the induction of low-grade inflammation. The presence of lipid-laden macrophages has occurred in infections caused by opportunistic pathogens. Candida albicans is the major cause of candidiasis in immunocompromised patients, including those with diabetes mellitus. However, the role played by C. albicans in macrophage foaming and the associated inflammation is poorly understood. We investigated whether C. albicans induces foaming along with inflammation in macrophages and, if so, by which mechanism(s). We incubated THP-1 macrophages with heat-killed C. albicans (HKCA). HKCA-induced lipid accumulation in macrophages along with increased expression of inflammatory markers, including CD11b and CD11c or expression and secretion of IL-1β. HKCA also increased the expression of PPARγ, CD36, and FABP4 in macrophages. Mechanistically, we found that the foamy and inflammatory macrophage phenotype induced by HKCA requires FABP4 because disruption of FABP4 in macrophages either by chemical inhibitor BMS309404 or small interfering RNA (siRNA) abrogated foam cell formation and expression of inflammatory markers CD11b, CD11c, and IL-1β. Furthermore, HKCA-treated macrophages displayed high expression and secretion of MMP-9. Inhibition of FABP4 resulted in suppression of HCKA-induced MMP-9 production. Overall, our results demonstrate that C. albicans induces foam cell formation, inflammation, and MMP-9 expression in macrophages via the upregulation of FABP4, which may constitute a novel therapeutic target for treating C. albicans-induced atherosclerosis.

1 January 2025 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
HAHaya AlAbduljader
Haya AlAbduljader
HAHalemah Alsaeed
Halemah Alsaeed
AAAmenah Alrabeea
Amenah Alrabeea
ASAmeenah Sulaiman
Ameenah Sulaiman
MHMohammed Haider
Mohammed Haider
FAFatema Al-Rashed
Fatema Al-Rashed
Metabolic‐endotoxemia, characterized by the translocation of lipopolysaccharide (LPS) from Gram‐negative bacteria into the bloodstream, is a key contributor to chronic low‐grade inflammation associated with obesity and type 2 diabetes. This condition exacerbates metabolic disruptions by activating Toll‐like receptor 4 (TLR4) on macrophages, leading to the release of pro‐inflammatory cytokines and subsequent insulin resistance. Eicosapentaenoic acid (EPA; C20:5 (n‐3)), an omega‐3 polyunsaturated fatty acid, has demonstrated anti‐inflammatory and antioxidative properties, but its precise mechanisms of action in mitigating LPS‐induced stress remain unclear. This study investigates the pathways through which C20:5 (n‐3) alleviates LPS‐induced oxidative stress and inflammation in macrophages. C20:5 (n‐3) pretreatment significantly reduced LPS‐induced inflammatory responses, decreasing IL‐1β and IL‐6 expression and IL‐1β secretion, and lowering the percentage of HLA‐DR + macrophages. C20:5 (n‐3) also attenuated ER stress, evidenced by reduced expression of ATF4, DDIT3, HSPA5/GRP78, BIP, and CHOP at both gene and protein levels. Oxidative stress was mitigated, as shown by decreased HIF1α expression, reduced ROS levels, and preservation of mitochondrial membrane potential. Importantly, C20:5 (n‐3) increased the expression of PPARα and FABP5 while inhibiting NF‐κB activation independently of the TLR4‐IRF5 pathway. The protective effects of C20:5 (n‐3) was abolished by PPARα inhibition with GW9662, indicating that C20:5 (n‐3)’s action is PPARα‐dependent. This study highlights the modulatory role of C20:5 (n‐3) in alleviating LPS‐induced oxidative stress and inflammation in macrophages through activation of the FABP5/PPARα/NF‐κB axis, independently of TLR4‐IRF5 signaling. These findings reveal a novel mechanism for C20:5 (n‐3)’s anti‐inflammatory effects and suggest that targeting the FABP5/PPARα pathway may offer therapeutic potential for treating metabolic disorders associated with chronic inflammation.